NYSE: PXP10 Inc Stock
$10.78-0.12 (-1.1%)
Updated Jan 30, 2026
PX Price
$10.78
Fair Value Price
N/A
Market Cap
$1.19B
52 Week Low
$8.68
52 Week High
$13.85
P/E
77x
P/B
3.44x
P/S
3.97x
PEG
0.13x
Dividend Yield
1.43%
Revenue
$301.31M
Earnings
$15.33M
Gross Margin
100%
Operating Margin
15.64%
Profit Margin
5.1%
Debt to Equity
1.56
Operating Cash Flow
$28M
Beta
0.98
Next Earnings
Mar 4, 2026
Ex-Dividend
N/A
Next Dividend
N/A
PX Overview
P10, Inc. manages private market investments across asset classes and geographies. Its portfolio of invetment options includes private equity, venture capital, impact investing, and private credit.The company's clients include pension funds, endowments, foundations, corporate pensions and financial institutions. P10 was founded in 1992 and is headquartered in Dallas, TX.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine PX's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Asset Management
Industry Rating
D
PX
Ranked#30 of 82
Ranked#30 of 82
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $9.30 | A | |
| $12.28 | A | |
| $53.28 | B |
Be the first to know about important PX news, forecast changes, insider trades & much more!
PX News
Overview
Due Diligence Score
–
Industry Average (33)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how PX scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
PX ($10.78) is trading below its intrinsic value of $30.11, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
PX is poor value based on its earnings relative to its share price (77x), compared to the US market average (43.06x)
P/E vs Market Valuation
PX is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more PX due diligence checks available for Premium users.
Valuation
PX price to earnings (PE)
For valuing profitable companies with steady earnings
Company
77x
Industry
38.55x
Market
43.06x
PX is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
PX is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
PX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
3.44x
Industry
2.8x
PX is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
PX price to earnings growth (PEG)
For valuing profitable companies with growth potential
PX is good value based... subscribe to Premium to read more.
PEG Value Valuation
PX's financial health
Profit margin
Revenue
$75.9M
Net Income
$2.1M
Profit Margin
2.8%
PX's Earnings (EBIT) of $47.12M... subscribe to Premium to read more.
Interest Coverage Financials
PX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$936.0M
Liabilities
$539.2M
Debt to equity
1.56
PX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$8.6M
Investing
$1.9M
Financing
$13.5M
PX's operating cash flow ($27.77M)... subscribe to Premium to read more.
Debt Coverage Financials
PX vs Asset Management Stocks
P10 Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.